FDA regulations are influencing medical practice standards and abortion pill usage trends, involving the AMA and Guttmacher Institute.
2 reports, 2 independent
Updated Jun 22
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA regulations are influencing medical practice standards and abortion pill usage trends, involving the AMA and Guttmacher Institute.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Data released by the Guttmacher Institute indicates that patient flows within the abortion care market are showing a noticeable decline.Sub-event
- FDA policy changes affecting abortion pill access are occurring in Colorado, involving Hassan Abbas.Sub-event
FDA changes affect medical practice standards and abortion pill usage trends.1 source
Keep exploring
The entities involved
- FDA
-
American Medical Association
United States association of physicians and medical students
Nothing else this week.
-
Guttmacher Institute
research and policy organization
Related events
- Bills are being pushed through Congress, with the involvement of Josh Hawley, to restrict access to abortion pills and debate the scope of drug approval and safety studies.
- Industry trends are influenced by regulatory body requests, according to a recent report involving RTI International.
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
- Humane World for Animals petitioned the FDA and lobbied Congress regarding drug approval regulations.
- FDA guidance changes affect biosimilar approval, impacting Coherus Oncology, Inc.